R1	Has_value Arg1:T1 Arg2:T2	
*	OR T4 T5
R2	Has_value Arg1:T3 Arg2:T4	
R3	Subsumes Arg1:T8 Arg2:T10	
R4	Has_qualifier Arg1:T8 Arg2:T9	
R5	Has_qualifier Arg1:T8 Arg2:T11	
R6	Has_value Arg1:T7 Arg2:T12	
R7	Has_value Arg1:T13 Arg2:T14	
R8	Has_value Arg1:T15 Arg2:T16	
R9	Has_value Arg1:T17 Arg2:T18	
R10	multi Arg1:T20 Arg2:T19	
R11	Has_negation Arg1:T23 Arg2:T22	
R12	Has_index Arg1:T27 Arg2:T28	
R13	Has_index Arg1:T29 Arg2:T31	
R14	Has_index Arg1:T30 Arg2:T32	
R15	Has_temporal Arg1:T26 Arg2:T29	
R16	Has_index Arg1:T38 Arg2:T40	
R17	Has_index Arg1:T39 Arg2:T41	
R18	Has_negation Arg1:T37 Arg2:T36	
R19	Has_temporal Arg1:T35 Arg2:T38	
R20	Has_temporal Arg1:T37 Arg2:T38	
R21	Has_negation Arg1:T43 Arg2:T36	
R22	Has_temporal Arg1:T43 Arg2:T38	
R23	Has_index Arg1:T46 Arg2:T47	
R24	Has_index Arg1:T48 Arg2:T49	
R25	Has_negation Arg1:T45 Arg2:T44	
R26	Has_temporal Arg1:T45 Arg2:T46	
R27	Has_temporal Arg1:T35 Arg2:T39	
R28	Has_temporal Arg1:T37 Arg2:T39	
R29	Has_temporal Arg1:T43 Arg2:T39	
R30	Has_temporal Arg1:T45 Arg2:T48	
T1	Person 0 3	Age
T2	Value 5 20	20-70 years old
T3	Person 23 29	Gender
T4	Value 31 35	male
T5	Value 39 45	female
T8	Condition 86 110	hepatocellular carcinoma
T9	Qualifier 48 82	clinical or pathological diagnosis
T10	Condition 112 115	HCC
T11	Qualifier 131 140	untreated
T7	Observation 156 173	expected survival
T12	Value 173 183	> 3 months
T13	Measurement 186 202	Child-Pugh grade
T14	Value 206 207	A
T15	Measurement 216 225	KPS score
T16	Value 231 244	50-100 points
T17	Measurement 247 257	BCLC stage
T18	Value 261 264	0-B
T19	Procedure 297 308	hepatectomy
T20	Observation 282 308	indications of hepatectomy
T21	Subjective_judgement 311 384	Viable tumor resection confirmed by two highly qualified surgical doctors
T22	Negation 387 389	No
T23	Observation 390 422	other surgical contraindications
T24	Person 425 430	women
T25	Observation 438 457	reproductive period
T26	Procedure 477 490	contraception
T27	Temporal 491 518	in 28 days before treatment
T28	Reference_point 509 518	treatment
T29	Temporal 520 548	during the treatment process
T30	Temporal 553 579	in 28 days after treatment
T31	Reference_point 531 540	treatment
T32	Reference_point 570 579	treatment
T34	Person 582 585	Men
T35	Procedure 605 618	contraception
T36	Negation 623 633	prohibited
T37	Procedure 647 661	sperm donation
T38	Temporal 662 690	during the treatment process
T39	Temporal 695 721	in 28 days after treatment
T40	Reference_point 673 682	treatment
T41	Reference_point 712 721	treatment
T43	Procedure 634 642	donation
T44	Negation 745 755	prohibited
T45	Procedure 756 764	donation
T46	Temporal 765 793	during the treatment process
T47	Reference_point 776 785	treatment
T48	Temporal 798 823	in 28 days after treatmen
T49	Reference_point 815 824	treatment
T51	Undefined_semantics 827 901	In addition to the subjects, prohibitting other people taking this product
T52	Subjective_judgement 904 992	patients have a good understanding and could coordinate with investigators for the trial
T53	Post-eligibility 995 1183	Patients enrolled in the trial should sign an informed consent form, to indicate understanding the purpose and procedure of the trial, and patients volunteering to participate in the trial
